Intracellular Dynamics of Smad-Mediated TGFβ Signaling

Journal of Cellular Physiology

Volumn 197, Issue 2, 2003, Pages 261-271

  Greene, Robert M ^a   Nugent, Paul ^a   Mukhopadhyay, Partha ^a   Warner, Dennis R ^a   Pisano, M Michele ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; OLIGONUCLEOTIDE; SMAD BINDING ELEMENT OLIGONUCLEOTIDE; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; GELATINASE A; GELATINASE B; SMAD2 PROTEIN, MOUSE; SMAD3 PROTEIN, MOUSE; SMAD4 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CLEFT PALATE; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; DNA RESPONSIVE ELEMENT; DYNAMICS; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC PALATE MESENCHYMAL CELL; EXTRACELLULAR MATRIX; GELATINASE A GENE; GELATINASE B GENE; GENE; GENE EXPRESSION; INTRACELLULAR DYNAMICS; MESENCHYME; MESENCHYME CELL; MORPHOGENESIS; MOUSE; NONHUMAN; ONTOGENY; PALATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SMAD RESPONSE ELEMENT; TRANSACTIVATION; ACTIVE TRANSPORT; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; FEMALE; FETUS; GENE EXPRESSION REGULATION; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRACELLULAR FLUID; MALE; MESODERM; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PRENATAL DEVELOPMENT;

MAMMALIA; MURINAE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELLS, CULTURED; CLEFT PALATE; DNA-BINDING PROTEINS; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTRACELLULAR FLUID; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MESODERM; MICE; MICE, INBRED ICR; OLIGONUCLEOTIDES; PALATE; PHOSPHORYLATION; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0242348816     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10355     Document Type: Article

References (94)

1. Akiyoshi S, Inoue H, Hanai J-I, Kusanagi K, Nemoto N, Miyazono K, Kawabata M. 1999. c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads. J Biol Chem 274:35269-35277.
2. Blavier L, Lazaryev A, Groffen J, Heisterkamp N, DeClerck YA, Kaartinen V. 2001. TGF-beta3-induced palatogenesis requires matrix metalloproteinases. Mol Biol Cell 12:1457-1466.
3. Brown N, Yarram S, Mansell J, Sandy J. 2002. Matrix metalloproteinases have a role in palatogenesis. J Dent Res 81:826-830.
4. Brunet C, Sharpe P, Ferguson M. 1995. Inhibition of TGF-β3 (but not TGF-β1 or TGF-β2) activity prevents normal mouse embryonic palate fusion. Int J Dev Biol 39:345-355.
5. Chen X, Rubock M, Whitman M. 1996. A transcriptional partner for MAD proteins. Nature 383:691-696.
6. Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, Whitman M. 1997. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389:85-89.
7. Chen S-J, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J. 1999. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: Involvement of Smad3. J Invest Dermatol 112:49-57.
8. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
9. Cui X, Shuler C. 2000. The TGF-beta type III receptor is localized to the medial edge epithelium during palatal fusion. Int J Dev Biol 44:397-402.
10. D'Angelo M, Greene R. 1991. Transforming growth factor β modulation of glycosaminoglycan production by mesenchymal cells of the developing murine secondary palate. Dev Biol 145:374-378.
11. D'Angelo M, Chen J, Ugen K, Greene R. 1994. TGFβ1 regulation of collagen metabolism by embryonic palate mesenchymal cells. J Exp Zool 270:189-201.
12. Denissova N, Pouponnot C, Long J, He D, Liu F. 2000. Transforming growth factor β inducible independent binding of Smad to the Smad7 promoter. Proc Natl Acad Sci 97:6397-6402.
13. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier J-M. 1998. Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100.
14. Derynck R, Zhang Y, Feng X-H. 1998. Smads: Transcriptional activators of TGF-β responses. Cell 95:737-740.
15. Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M, ten Dijke P, Gressner A. 2001. Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phophorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. FEBS Lett 502:4-10.
16. Eickelberg O. 2001. Endless healing: TGF-β, Smads, and fibrosis. FEBS Lett 506:11-14.
17. Fitzpatrick D, Denhez F, Kondaiah P, Akhurst R. 1990. Differential expression of TGFβ isoforms in murine palatogenesis. Development 109:585-595.
18. Foitzik K, Paus R, Doetschman T, Dotto G. 1999. The TGF-β2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev Biol 212:278-289.
19. Gehris A, Greene R. 1992. Regulation of murine embryonic epithelial cell differentiation by transforming growth factors β. Differentiation 49:167-173.
20. Gehris A, D'Angelo M, Greene R. 1991. Immunodetection of the transforming growth factor-B1 and B2 in the developing palate. Int J Dev Biol 35:17-24.
21. Gehris A, Pisano M, Nugent N, Greene R. 1994. Regulation of TGFβ gene expression in embryonic palatal tissue. In Vitro Dev Biol 30A:671-679.
22. Glass C, Franco R, Weinberger C, Albert V, Evans R, Rosenfeld M. 1987. A c-erb-A binding site in rat growth hormone gene mediates trans-activation by thyroid hormone. Nature 329:738-741.
23. Greene R, Pisano M. 1989. Analysis of cell proliferation in developing orofacial tissue. In: Kimmel G, Kochhar D, editors. In vitro techniques in developmental toxicology: Use in defining mechanisms and risk parameters. Boston: CRC Press, Inc. pp 91-101.
24. Greene R, Pisano M. 2000. Pathways to transcription. Teratology 62:10-13.
25. Greene R, Nugent P, Pisano M, Weston W, Potchinsky M. 1998. Signal transduction pathways as targets for induced embryotoxicity. In: Slikker W, Chang L, editors. Handbook of developmental neurotoxicology. San Diego: Academic Press. pp 119-139.
26. Han Y-H, Tuan T-L, Hughes M, Wu H, Garner W. 2001. Transforming growth factor-β-and tumor necrosis factor-a-mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem 276:22341-22350.
27. Harendza S, Pollock A, Mertens P, Lovett D. 1995. Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J Biol Chem 270:18786-18796.
28. Hassell J, Orkin R. 1976. Synthesis and distribution of collagen in the rat palate during shelf elevation. Dev Biol 49:80-88.
29. Hocevar B, Brown T, Howe P. 1999. TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent Smad4-independent pathway. EMBO J 18:1345-1356.
30. Hong S, Isono M, Chen S, Iglesias-de la Cruz, Han D, Ziyadeh F. 2001. Increased glomerular and tubular expression of transforming growth factor-β1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 158:1653-1663.
31. Huhtala P, Tuuttila A, Chow L, Lohi J, Keski-Oja J, Tryggvason K. 1991. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem 266:16485-16490.
32. Ignotz R, Massagué J. 1990. Regulation of phenotype by transforming growth factor-β: Role of the extracellular matrix. In: Fisher PB, Phil M, editors. Mechanisms of differentiation. II. Boston: CRC Press. pp 183-200.
33. Itoh S, Itoh F, Goumans M-J, ten Dijke P. 2000. Signaling of transforming growth factor-β family members through Smad proteins. Eur J Biochem 267:6954-6967.
34. Janknecht R, Wells N, Hunter T. 1998. TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev 12:2114-2119.
35. Jonk L, Itoh S, Heldin C-H, ten Dijke P, Kruijer W. 1998. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273:21145-21152.
36. Kaartinen V, Voncken J, Schuler C, Warburton D, Bu D, Heisterkamp N, Groffen J. 1995. Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 11:415-421.
37. Kaartinen V, Cui X-M, Heisterkamp N, Groffen J, Shuler C. 1997. Transforming growth factor-β3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane. Dev Dynamics 209:255-260.
38. Kawabata M, Inoue H, Hanyu T, Imamura T, Miyazono K. 1998. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J 17:4056-4065.
39. Kim R, Wang D, Tsang M, Martin J, Huff C, de Caestecker M, Parks W, Meng X, Lechleider R, Wang T, Roberts A. 2000. A novel Smad nuclear interacting protein (SNIP1) supresses p300-dependent TGF-β signal transduction. Genes Dev 14:1605-1616.
40. Kusek J, Greene R, Nugent P, Pisano M. 2000. Expression of the E2F family of transcription factors during murine development. Int J Dev Biol 44:267-277.
41. Laemmle UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
42. Lehmann K, Janda E, Pierreux C, Ryomaa M, Schulze A, McMahon M, Hill C, Beug H, Downward J. 2000. Raf induces TGF-β production while blocking its apoptotic but not invasive responses: A mechanism leading to increased malignancy in epithelial cells. Genes Dev 14:2610-2622.
43. Linask K, D'Angelo M, Gehris A, Greene R. 1991. Transforming growth factor-beta receptor profiles of human and murine embryonic palate mesenchymal cells. Exp Cell Res 192:1-9.
44. Liu J, Tseu I, Wang J, Tanswell K, Post M. 2000. Transforming growth factor β2, but not β1 and β3, is critical for early rat lung branching. Dev Dynamics 217:343-360.
45. Macias-Silva M, Abdollah S, Hoodless P, Pirone R, Attisano L, Wrana J. 1996. MADR2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:1215-1224.
46. Massagué J. 1998. TGF-β signal transduction. Ann Rev Biochem 67:753-791.
47. Massagué J, Chen Y-G. 2000. Controlling TGF-β signaling. Genes Dev 14:627-644.
48. McCartney-Francis N, Wahl S. 1994. Transforming growth factor β: A matter of life and death. J Leukocyte Biol 55:401-409.
49. Morris-Wiman J, Du Y, Brinkley L. 1999. Occurrence and temporal variation in matrix metalloproteinases and their inhibitors during murine secondary palatal morphogenesis. J Craniofac Genet Dev Biol 19:201-212.
50. Moustakas A, Souchelnytskyi S, Heldin CH. 2001. Smad regulation in TGF-beta signal transduction. J Cell Sci 114:4359-4369.
51. Mukhopadhyay P, Greene R, Weinrich M, Zacharias W, Pisano M. Developmental gene expression profiling of mammalian fetal orofacial tissue. Dev Dynamics (submitted for publication).
52. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin C-H, Miyazono K, ten Dijke P. 1997. TGF-β receptor-mediated signalling through Smad2, Smad3, and Smad4. EMBO J 16:5353-5362.
53. Nishihara A, Hanai J-I, Imamura T, Miyazono K, Kawabata M. 1999. E1A inhibits transforming growth factor-β signaling through binding to Smad proteins. J Biol Chem 274:28716-28723.
54. Nugent P, Greene R. 1995. Antisense oligonucleotides to CRABP-I and CRABP-II alter the expression of TGF-β3, RAR-β, and tenascin in primary cultures of embryonic palate cells. In Vitro Cell Dev Biol 31A:553-558.
55. Nugent P, Ma L, Greene R. 1998. Differential expression and biological activity of retinoic acid-induced TGF-β isoforms in embryonic palate mesenchymal cells. J Cell Physiol 177:36-46.
56. Nugent P, Kusek J, Pisano M, Greene R. 2001. Convergence of cAMP, TGF-β, and retinoic acid signaling pathways in cells of the embryonic palate. Life Sci 69:2091-2102.
57. Pelton R, Hogan B, Miller D, Moses L. 1990. Differential expression of genes encoding TGF-B1, B2, and B3 during mouse palate formation. Dev Biol 141:456-460.
58. Pelton R, Saxena B, Jones M, Moses H, Gold L. 1991. Immunohistochemical localization of TGF-B1, TGF-B2, and TGF-B3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105.
59. Piek E, Ju W, Heyer J, Escalante-Alcalde D, Stewart C, Weinstein M, Deng C, Kucherlapati R, Bottinger E, Roberts A. 2001. Functional characterization of transforming growth factor β signaling in Smad2-and Smad3-deficient fibroblasts. J Biol Chem 276:19945-19953.
60. Pisano M, Mukhopadhyay P, Greene R. Molecular fingerprinting of TGFβ-treated embryonic maxillary mesenchymal cells. Orthodontics Craniofacial Res (submitted for publication).
61. Poncelet A-C, de Caestecker M, Schnaper H. 1999. The transforming growth factor-β/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int 56:1354-1365.
62. Potchinsky M, Nugent P, Greene R. 1996. Effects of dexamethasone on the expression of TGFβ in mouse embryonic palate mesenchymal cells. J Cell Physiol 166:380-386.
63. Pratt R, Goggins J, Wilk A, King C. 1973. Acid mucopolysaccharide synthesis in the secondary palate of the developing rat at the time of rotation and fusion. Dev Biol 32:230-237.
64. Proetzel G, Pawlowski S, Wiles M, Yin M, Boivin G, Howles P, Ding J, Ferguson M, Doetschman T. 1995. Transforming growth factor-β3 is required for secondary palate fusion. Nat Genet 11:409-414.
65. Reisdorf P, Lawrence D, Sivian V, Klising E, Martin M. 2001. Alteration of transforming growth factor-beta1 response involves down-regulation of Smad3 in myofibroblasts from skin fibrosis. Am J Pathol 159:263-272.
66. Rizzino A. 1988. Transforming growth factor-β: Multiple effects on cell differentiation and extracellular matrices. Dev Biol 130:411-422.
67. Roach J, Choi S, Schaub R, Leach R, Roodman G, Reddy S. 1998. Further characterization of the murine collagenase (type IVB) gene promoter and analysis of mRNA expression in murine tissues. Gene 208:117-122.
68. Roberts A, Flanders K, Kondaiah P, Thompson N, Van Obberghen-Schilling E, Wakefield L, Rossi P, De Crombrugghe B, Heine U, Sporn M. 1988. Transforming growth factor β: Biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Progress Hormone Res 44:157-195.
69. Romano L, Runyan R. 2000. Slug is an essential target of TGF-β2 signaling in the developing chicken heart. Dev Biol 223:91-102.
70. Saika S, Okada Y, Miyamoto T, Ohnishi Y, Ooshima A, McAvoy J. 2001. Smad translocation and growth suppression in lens epithelial cells by endogenous TGFβ2 during wound repair. Exp Eye Res 72:679-686.
71. Sasse J, Gallagher S. 1991. Staining protein gels. In: Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, Struhl K, editors. Current protocols in molecular biology. New York: John Wiley and Sons. pp 10.6.1-10.6.8.
72. Shi Y. 2001. Structural insights on Smad function in TGF-β signaling. Bioessays 23:223-232.
73. Sirard C, de la Pompa J, Elia A, et al. 1998. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev 12:107-19.
74. Souchelnytskyi S, Ronnstrand L, Heldin C, ten Dijke P. 2000. Phosphorylation of Smad signaling proteins by receptor serine/threonine kinases. In: Reith D, editor. Protein kinase protocols. Totowa, NJ: Humana Press, Inc. pp 107-120.
75. Stroschein S, Wang W, Zhou S, Zhou Q, Luo K. 1999. Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 286:771-774.
76. Taylor L, Khachigian L. 2000. Induction of platelet derived growth factor B-chain expression by transforming growth factor-β involves transactivation by Smads. J Biol Chem 275:16709-16716.
77. ten Dijke P, Miyazono K, Heldin C-H. 2000. Signaling inputs converge on nuclear effectors in TGF-β signaling. TIBS 25:64-70.
78. Topper J, DiChiara M, Brown J, Williams A, Falb D, Collins T, Gimbrone M. 1998. CREB binding protein is a required coactivator for Sad-dependent, transforming growth factor β transcriptional responses in endothelial cells. Proc Natl Acad Sci 95:9506-9511.
79. Vian J, Sun Y. 1997. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 17:6330-6338.
80. Vindevoghel L, Lechleider R, Kon A, de Caestecker M, Uitto J, Roberts A, Mauviel A. 1998. Smad3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor β. Proc Natl Acad Sci USA 95:14769-14774.
81. Warner D, Pisano M, Greene R. 2002. Expression of the nuclear coactivators CBP/p300 in developing craniofacial tissue. In Vitro Cell Dev Biol 38:48-53.
82. Wilk A, King C, Pratt R. 1978. Chlorcyclizine induction of cleft palate in the rat: Degradation of palatal glycosaminoglycans. Teratology 18:199-209.
83. Wong C, Rougier-Chapman E, Frederick J, Datto M, Liberti N, Wang X-F. 1999. Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor β. Mol Cell Biol 19:1821-1830.
84. Wrana J. 2000. Regulation of Smad activity. Cell 100:189-192.
85. Wrana J, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massagué J. 1992. TGFB signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014.
86. Wu R-Y, Zhang Y, Feng X-H, Derynck R. 1997. Heteromeric and homomeric interactions correlate with signaling activity and functional co-operativity of Smad3 and Smad4/DPC4. Mol Cell Biol 17:2521-2528.
87. Yagi K, Goto D, Hamamoto T, Tekanoshita S, Kato M, Miyazono K. 1999. Alternatively spliced variant of Smad2 lacking exon3. J Biol Chem 274:703-709.
88. Yamamura Y, Hua X, Bergelson S, Lodish H. 2000. Critical role of Smads and AP-1 complex in transforming growth factor-β-dependent apoptosis. J Biol Chem 275:36295-36302.
89. Yingling J, Datto M, Wong C, Frederick J, Liberti N, Wang X-F. 1997. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol Cell Biol 17:7019-7028.
90. Yue J, Frey R, Mulder K. 1999. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFβ. Oncogene 18:2033-2037.
91. Zawel L, Dai J, Buckhaults P, Zhou S, Kinzler K, Vogelstein B, Kern S. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1:611-617.
92. Zhang Y, Derynck R. 1999. Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol 9:274-279.
93. Zhang Y, Feng X, Derynck R. 1998. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 394:909-913.
94. Zhou S, Zawel L, Lengauer C, Kinzler K, Vogelstein B. 1998. Characterization of human FAST-1, a TGFβ and activin signal transducer. Mol Cell 2:121-127.